# Kry account plan

> Kry (Livi in the UK and France) is a Stockholm-based provider of digital and physical healthcare with revenue of SEK 2.5 billion in 2025.

## At a glance

Kry International AB is a private, investor-backed healthcare provider that combines digital consultations with a network of physical clinics in Sweden, Norway, France and the UK. Livi, the name used in the UK and France, is being rebranded to Kry; the release of 8 September 2026 says the Livi brand will be gradually phased out and the wider business remains unchanged. FY2024 net sales were 2,489,581 kSEK with a loss after financial items of -525,153 kSEK, and the company states 2025 revenue of SEK 2.5 billion and EBITDA of SEK 17 million. The group had an average of 1,591 employees in 2024 and approximately 4,000 healthcare professionals.

## Business units

- **Primary healthcare** (2,010,990 kSEK of 2,489,581 kSEK FY2024 net sales): The largest revenue line, up from 1,862,010 kSEK in 2023. In Sweden Kry has 254,000 registered patients at 29 healthcare centres across seven regions at the 2024 year end, with a Hermelinen Group acquisition in March 2025 adding capacity in Norrbotten.
- **B2B/B2C** (405,321 kSEK in FY2024): Up from 313,584 kSEK in 2023. The report names occupational healthcare and employee care in Sweden, the UK and France, and a new B2B offering launched in April 2025 after PBM activities moved under the Kry brand.
- **Other** (73,270 kSEK in FY2024): Other revenue, up from 19,375 kSEK in 2023.
- **Sweden** (1,788,790 kSEK of FY2024 net sales): The most mature market, with an average of 1,100 employees. Kry has 284,000 registered patients and physical services in 17 of 21 regions, according to the November 2026 release.
- **France** (417,095 kSEK of FY2024 net sales): 1 million digital appointments in 2024, almost 10% of all remote meetings in France, with 35% annual growth. Kry plans to open its first medical centre in Paris in September 2026.
- **UK (Livi)** (247,756 kSEK of FY2024 net sales): Down from 294,443 kSEK in 2023. Works with the insurer Vitality and signed an eMed agreement in December 2024; the Klarna partnership of June 2026 gives Klarna UK members access to Kry consultations.
- **Norway** (35,940 kSEK of FY2024 net sales): Two public primary care units, in Alesund and Gardermoen, in a publicly funded market that is still largely closed to private providers.

## Strategic priorities

- **Reach profitability**: The annual report states Kry's main goal is to become profitable. The EBITDA margin improved from -19.5% to -4.4% in 2024, and the company states 2025 EBITDA of SEK 17 million.
- **Scale the digiphysical model**: Kry plans to expand its digital offloading model across its four markets, increasing the share of digital-first consultations and integrating digital and physical healthcare.
- **One European brand**: Livi in the UK and France becomes Kry, so that the shared technology platform and ways of working carry the same name everywhere.
- **Grow in France**: The 2025 strategy was to expand on a large scale by launching specialist areas and new disciplines such as paediatrics, obesity and gynaecology, and a first medical centre opens in Paris in September 2026.
- **Consolidate Sweden through acquisition**: Kry announced on 12 November 2026 the acquisition of Min Doktor, which had approximately SEK 400 million revenue in 2025; it is subject to regulatory approval.

## Latest results

Kry states that in 2025 revenue amounted to SEK 2.5 billion and EBITDA to SEK 17 million, against an EBITDA of SEK -505 million in 2024 and a margin of -4.4%. The FY2024 results release of 24 June 2025 said all markets returned a profit at the end of 2024 and that the trend continued in the first quarter of 2025. No quarterly report for 2026 is in the documents read.

## Investments and deals

- **Min Doktor acquisition**: Announced 12 November 2026; Apotek Hjartat and EQT Ventures become shareholders in Kry. Min Doktor had nearly 100 sites, revenue of approximately SEK 400 million and EBITDA of approximately SEK 27 million in 2025.
- **Bolt-on clinic acquisitions**: Since 2020 Kry has acquired Helsa, PBM, Citylakarna, Trygga Kliniken, Adavia Group, Hudlakartjanst and Hermelinen; Medinord was acquired in 2026.
- **Financing and ownership restructuring**: EUR 20 million convertible loan in March 2024 and a conversion in October 2024 that raised equity by SEK 1,468 million to SEK 448 million.
- **New physical sites**: Kry took over operation of Kungsbacka Lattakut in Region Halland on 1 January 2025 and plans a Paris medical centre in September 2026.

## Challenges and risks

- **Regional repayment claims**: Region Stockholm demands SEK 48 million and Region Skane SEK 18.8 million back; Kry considers both unfounded and has disputed them.
- **Regulatory dependence**: Policy decisions in the publicly funded systems of Sweden, France and the UK can significantly affect Kry, and the Norwegian public primary care market is largely closed to private providers.
- **Loss-making history**: The FY2024 loss after financial items was -525,153 kSEK and cash flow from operating activities was -509,302 kSEK.
- **UK scale**: UK revenue fell from 294,443 kSEK to 247,756 kSEK in 2024, and the annual report says challenges surrounding scalability remain in the UK.

## What leadership says

> "We have grown from being a Swedish digital challenger into a large and established healthcare provider across several European markets." — Kalle Conneryd Lundgren, CEO, Kry press release on the Livi rebrand, 8 September 2026

> "Our ambition has always been the same: to build Europe's leading healthcare provider and help move healthcare into the future." — Johannes Schildt, Founder and Chair, Kry press release on the Livi rebrand, 8 September 2026

> "We are using AI in production" — Kalle Conneryd Lundgren, COO of Livi (now CEO), HTN interview, 6 March 2024


## Where a supplier can help

- **Clinic operations and productivity tooling**: Kry adds clinics through acquisitions such as Min Doktor and Hermelinen and cites record measured productivity, so scheduling, patient-flow and admin-reduction suppliers can help integrate sites.
- **Integration of acquired businesses**: With the Min Doktor deal and a list of bolt-on acquisitions, integration, IT consolidation and finance-systems support are relevant to its consolidation priority.
- **Cost and billing compliance**: The SEK 48 million and SEK 18.8 million repayment claims point to a need for billing audit, appointment registration and compliance tooling.
- **Rebrand and partnership marketing**: The shift from Livi to Kry in the UK and France, and partnerships such as Klarna, create work for brand, patient-acquisition and partner-channel suppliers.

_Tamtam's reading of the priorities and challenges above, not the company's own words._

## Key documents

### [Annual Report and Consolidated Accounts 2024, KRY International AB (556967-0820)](https://assets.ctfassets.net/h8qzhh7m9m8u/6rIsx9D5tu1JOCWJmM5QUU/7c99070296c92ecb6f38074b443f897e/ENG_Annual_Report_Kry_Int_AB_2024_FINAL_1__1_.pdf)

Annual report

- Kry International AB (Stockholm; "Kry/Livi" platform) is a private, VC-backed digital and physical ("digiphysical") healthcare provider operating in Sweden, Norway, France and the UK; the largest holders (more than 10%) at 31 Dec 2024 were 2731065 Ontario Limited and Healthcare of Ontario Pension Plan Trust Fund.
- FY2024 net sales were SEK 2,497 million, up 13.3% from SEK 2,203 million in 2023; loss after financial items was -525,153 kSEK (2023: -905,706 kSEK).
- The EBITDA margin improved from -19.5% to -4.4% in 2024; EBITA margin was -12.3% versus -31.5% in 2023.
- Revenue by line (kSEK): Primary healthcare 2,010,990; B2B/B2C 405,321; Other 73,270. By market: Sweden 1,788,790, France 417,095, UK 247,756, Norway 35,940.
- Group average headcount was 1,591 in 2024 (Sweden 1,100, France 269, UK 188, Norway 33); more than 3,000 healthcare employees are contracted.
- Ownership was restructured in October 2024: convertible loans were converted, lifting equity by SEK 1,468 million to SEK 448 million (previously SEK -442 million); new financing of EUR 30 million in total.
- In France Kry held 1 million digital appointments in 2024, almost 10% of all remote meetings in the country, with annual growth of 35%.
- Risks stated: public-funding policy changes, plus repayment demands of SEK 48 million (Region Stockholm) and SEK 18.8 million (Region Skane), which Kry disputes.
- Founder Johannes Schildt became Chairman and Kalle Conneryd Lundgren CEO in December 2024. The report states the main goal is to become profitable.

### [Kry to improve access to and range of healthcare services through acquisition of Min Doktor and new partnership with Apotek Hjartat](https://kry.health/news/kry-to-improve-access-to-and-range-of-healthcare-services-through-acquisition-of-min-doktor)

Report · 2026-11-12

- On 12 November 2026 Kry announced the acquisition of Min Doktor, described as one of the largest digiphysical healthcare providers in Sweden; it is subject to customary regulatory approval.
- Kry now says it operates in five markets: United Kingdom, France, Sweden, Norway and Ireland, with 72 physical care units and more than 3,000 active clinicians.
- Kry's 2025 results as stated by the company: revenue SEK 2.5 billion and EBITDA SEK 17 million.
- Min Doktor 2025: revenue of approximately SEK 400 million and EBITDA of approximately SEK 27 million; 49.5% owned by Apotek Hjartat (ICA Group). Apotek Hjartat and EQT Ventures become shareholders in Kry.
- In Sweden Kry has 284,000 registered patients and physical services in 17 of 21 regions; the app has been downloaded more than 8 million times and more than 14 million digital consultations completed.
- Prior acquisitions since 2020: Helsa, PBM, Cityläkarna, Trygga Kliniken, Adavia Group, Hudläkartjänst and Hermelinen; Medinord in 2026. Stifel was sole financial adviser.

### [Kry scales its care model across Europe as Livi becomes Kry in the UK and France](https://kry.health/news/kry-scales-its-care-model-across-europe-as-livi-becomes-kry-in-the-uk-and-france)

Report · 2026-09-08

- Livi, the name under which Kry operates in the UK and France, is rebranding to Kry; the Livi brand will be "gradually phased out" in both countries. This is a rebrand, not an exit or sale: "The wider business will otherwise remain unchanged."
- Kry plans to open its first medical centre in Paris in September 2026.
- Kry operates in Sweden, Norway, the United Kingdom and France, runs 72 clinics and conducts more than 200,000 consultations every month.
- Across its markets Kry has delivered more than 14 million patient consultations and employs approximately 4,000 healthcare professionals.
- In 2024 Kry accounted for nearly 10 per cent of all remote consultations in France and grew by 35 per cent there.
- CEO Kalle Conneryd Lundgren says a shared brand makes it easier to "build trust and collaborate with partners across borders".

### [Kry drives growth in 2024 with its best results to date (FY2024 results release)](https://kry.health/news/kry-drives-growth-in-2024-with-its-best-results-to-date)

Report · 2025-06-24

- Kry reported FY2024 revenue of 2,5bnSEK, a 22% increase since the 2022 reporting period, and said all markets returned a profit at end of 2024.
- Group EBITDA was SEK -505 million for 2024 versus -960million in 2023; EBITDA margin improved from -19.5% to -4.4%.
- The positive trend continued in the first quarter of 2025 with continued growth and financial result improvements.
- More than 60 physical units and over 12 million patient consultations throughout Europe.
- Sweden: close to 16,000 new registered patients at its clinics in 2024. UK: actively seeking its first physical site. France: almost 10% of all remote meetings in the country and 35% annual growth.
- Plan: scale the digital offloading model across its four markets (Sweden, France, UK, Norway).

### [Featured interview: "We don't believe there is such a thing as digital or physical healthcare; it's just healthcare" (HTN Health Tech News)](https://htn.co.uk/2024/03/06/featured-interview-we-dont-believe-there-is-such-a-thing-as-digital-or-physical-healthcare-its-just-healthcare-kalle-conneryd-lundgren-coo-at-livi/)

Executive talk · Kalle Conneryd Lundgren, COO of Livi (now CEO of Kry) · 2024-03-06

- Conneryd Lundgren (then COO, since December 2024 CEO) says "We don't believe there is such a thing as digital or physical healthcare; it's just healthcare": every patient journey will combine digital and physical parts.
- The Nordics are the most mature market, with about 25 percent of the population registered; Kry operates there under the Kry name and in France and the UK as Livi.
- In the UK Livi has about 450 clinicians, works across approximately 1,500 practices, has delivered just over two million consultations and can cover over 11 million NHS patients.
- In March/April 2024 Livi planned to launch a "virtual practice partner" package for NHS partners in the UK, as already offered in France and Sweden.
- AI is used in production to remove administration from clinicians, "not to replace them or replace their decision-making".
- Ambition in 10 years: be the largest primary care provider in Europe and at least double the around 5,000 clinicians employed.
- Policy asks: faster API access to partner infrastructure and a way to partner at scale, as the UK has no national billing system.

## Questions about Kry

### What does Kry do?

Kry is a European healthcare provider that combines digital care with a network of physical clinics, covering primary care, specialist care and occupational health in Sweden, Norway, France, the UK and, per the November 2026 release, Ireland.

### Is Livi still operating in France and the UK?

Livi is being rebranded to Kry in the UK and France; the release of 8 September 2026 says the Livi brand will be gradually phased out and the business otherwise remains unchanged. No sale or closure is stated.

### What is Kry's revenue?

Kry's FY2024 net sales were 2,489,581 kSEK, and the company states that 2025 revenue was SEK 2.5 billion with EBITDA of SEK 17 million.

### Who runs Kry?

Kalle Conneryd Lundgren has been CEO since December 2024; founder Johannes Schildt is Chairman.

_Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-19)_
